Statistics for Trevi Therapeutics (id:6743 TRVI)

Valuation metrics

Market cap

219.84M

Enterprise value

155.46M

Trailing P/E (ttm)

-10.00

Forward P/E

-5.96

PEG ratio

-5.96

Price/Sales (ttm)

Price/Book (mrq)

3.66

Enterprise Value/Revenue

Enterprise Value/EBITDA

-3.23

Overview

Shares outstanding

76.87M

Float

47.77M

Shares short

1.72M

% Held by insiders

0.01%

% Held by institutions

0.80%

Average volume (10 days)

599.34K

Average volume (90 days)

Price summary

52-Week low

0.97

52-Week high

4.00

52-Week change

62.41%

Beta

1.01

50-Day moving average

3.15

200-Day moving average

2.86

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-36.57%

Return on equity

-59.65%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-48,070,000.00

Net income to common (ttm)

-44,317,000.00

Diluted EPS (ttm)

-0.44

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

65.49M

Total cash per share (mrq)

0.85

Total debt (mrq)

1.11M

Total Debt/Equity (mrq)

1.89

Current ratio (mrq)

738.10%

Book value per share (mrq)

0.78

Cash flow

Cash flow statement

-35,065,000.00

Levered free cash flow (LFCF)

-19,262,124.00